Waitematā DHB chief executive Dale Bramley, flanked by director-general of health Ashley Bloomfield and a sign language interpreter, addresses the media briefing on COVID-19 at Auckland City Hospital this afternoon
“This is an important issue and we have provided advice to the Government around this”
The Government is considering what further COVID-19
Your patient with type 2 diabetes is not reaching HbA1c target after lifestyle changes and treatment with metformin. So what next? Dr Rick Cutfield takes an expert look at the second-line treatment options available in New Zealand, including newly funded DPP-4 inhibitor vildagliptin.